NCT03028207

A Cross-sectional Study on COPD Prevalence

New Study on the Prevalence of COPD in Spain EPI-Scan-II Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 9,362 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality worldwide and hence, estimating its prevalence is important. Since 2007, there are few data on the prevalence of COPD in the general population in Spain. The main objective of this epidemiological observational study is to estimate the prevalence of COPD in residents of Spain among the population over 40 years of age. The subjects will be distributed in two groups depending on the presence and absence of COPD. The study will have a single visit in which a brief interview will take place and subjects will need to complete the medical tests the case report form with a series of questionnaires. No drugs will be administered in this study.

Conditions

• Pulmonary Disease, Chronic Obstructive

Interventions

Type	Name	Description
PROCEDURE	Medical tests	During Visit 1, subjects will go through medical tests including spirometry, bronchodilation test, pulse oximetry, cooximetry, and bioimpedance. Additional tests will be performed at up to 9 centers such as pulmonary diffusion test, 6 minute walk test, CT during the same visit.
OTHER	Questionnaire	During Visit 1, subjects will be given an Electronic Case Report Form (eCRF) with a series of questionnaire such as Health Related Quality of Life (HRQoL) CAT questionnaire, HADS anxiety scale, YPAS physical activity questionnaire, ECSC respiratory symptoms questionnaire, occupational exposure related questionnaire, MMSE questionnaire, Fagerstrom test, Prochaska test.

Timeline

• Start date: 2017-03-09
• Primary completion: 2019-03-01
• Completion: 2019-03-01
• First posted: 2017-01-23
• Last updated: 2019-06-28

Locations

20 sites across 1 country: Spain